Insider trades
Christopher Peetz, CEO of Mirum Pharmaceuticals MIRM, has filed 0 purchases and 22 sales on the open market. Over the past 12 months that comes to a net sale of $8.9M. The latest trade was on 06/01.
Christopher Peetz
CEO
- Company
- Mirum Pharmaceuticals MIRM
- First filing
- 23/01/05
- Trades
- 70 trades
- Buys / sales
- 0 / 22
- 12-month net buying
- −$8.9M
- Last trade
- 06/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
MIRM | Open-market sale10b5-1 plan | 06/01 | 06/02 | 30,000 sh6 trades | $95.84avg. | $2,875,103.34 | −13.4% |
| Open-market sale | 03/16 | 03/17 | 40,985 sh | $91.98 | $3,769,800.3 | −17.4% | |
| Open-market sale | 02/02 | 02/03 | 9,108 sh | $103.30 | $940,856.4 | −5.4% | |
| Open-market sale | 01/26 | 01/27 | 6,831 sh | $96.19 | $657,073.89 | −3.9% | |
| Open-market sale | 01/22 | 01/23 | 7,098 sh | $93.33 | $662,456.34 | −4.2% | |
| Open-market sale10b5-1 plan | 25/08/11 | 25/08/12 | 40,000 sh | $62.00 | $2,480,000 | −22.4% | |
| Open-market sale10b5-1 plan | 25/08/07 | 25/08/08 | 40,000 sh | $55.25 | $2,210,000 | −22.4% | |
| Open-market sale | 25/03/17 | 25/03/18 | 27,279 sh | $44.21 | $1,206,004.59 | −16.4% | |
MIRM | Open-market sale10b5-1 plan | 25/03/03 | 25/03/04 | 40,000 sh2 trades | $46.91avg. | $1,876,352.64 | −25.7% |
| Open-market sale | 25/02/03 | 25/02/04 | 9,102 sh | $48.22 | $438,898.44 | −7.3% | |
| Open-market sale | 25/01/24 | 25/01/27 | 6,837 sh | $47.92 | $327,629.04 | −5.2% | |
| Open-market sale | 25/01/07 | 25/01/08 | 7,489 sh | $42.82 | $320,678.98 | −5.9% | |
| Open-market sale | 23/01/09 | 24/03/18 | 5,159 sh | $20.62 | $106,378.58 | −5.3% | |
| Open-market sale | 24/02/02 | 24/02/05 | 6,013 sh | $26.19 | $157,480.47 | −5.5% | |
| Open-market sale | 24/01/08 | 24/01/09 | 5,209 sh | $28.03 | $146,008.27 | −4.5% | |
| Open-market sale | 23/07/03 | 23/07/05 | 5,498 sh | $25.65 | $141,023.7 | −4.6% |